Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 198

1.

Parkinson disease: Unravelling the nonmotor mysteries of Parkinson disease.

Chaudhuri KR, Sauerbier A.

Nat Rev Neurol. 2015 Dec 30;12(1):10-1. doi: 10.1038/nrneurol.2015.236. No abstract available.

PMID:
26714657
2.

Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease.

Martinez-Martin P, Leentjens AF, de Pedro-Cuesta J, Chaudhuri KR, Schrag AE, Weintraub D.

Mov Disord. 2015 Dec 22. doi: 10.1002/mds.26522. [Epub ahead of print] Review.

PMID:
26695691
3.

Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's Disease.

Fauser M, Löhle M, Ebersbach G, Odin P, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Storch A.

J Parkinsons Dis. 2015 Nov 26;5(4):737-41. doi: 10.3233/JPD-150656.

PMID:
26639660
4.

A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain.

Rascol O, Zesiewicz T, Chaudhuri KR, Asgharnejad M, Surmann E, Dohin E, Nilius S, Bauer L.

J Clin Pharmacol. 2015 Dec 2. doi: 10.1002/jcph.678. [Epub ahead of print]

PMID:
26626320
5.

Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study.

Kass-Iliyya L, Javed S, Gosal D, Kobylecki C, Marshall A, Petropoulos IN, Ponirakis G, Tavakoli M, Ferdousi M, Chaudhuri KR, Jeziorska M, Malik RA, Silverdale MA.

Parkinsonism Relat Disord. 2015 Dec;21(12):1454-60. doi: 10.1016/j.parkreldis.2015.10.019. Epub 2015 Nov 3.

6.

Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.

Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group.

Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19.

PMID:
26494524
7.

Non motor subtypes and Parkinson's disease.

Sauerbier A, Jenner P, Todorova A, Chaudhuri KR.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S41-6. doi: 10.1016/j.parkreldis.2015.09.027. Epub 2015 Sep 11.

PMID:
26459660
8.

Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease.

Dafsari HS, Reddy P, Herchenbach C, Wawro S, Petry-Schmelzer JN, Visser-Vandewalle V, Rizos A, Silverdale M, Ashkan K, Samuel M, Evans J, Huber CA, Fink GR, Antonini A, Chaudhuri KR, Martinez-Martin P, Timmermann L; IPMDS Non-Motor Symptoms Study Group.

Brain Stimul. 2016 Jan-Feb;9(1):78-85. doi: 10.1016/j.brs.2015.08.005. Epub 2015 Aug 19.

PMID:
26385442
9.

New clinical trials for nonmotor manifestations of Parkinson's disease.

Schrag A, Sauerbier A, Chaudhuri KR.

Mov Disord. 2015 Sep 15;30(11):1490-504. doi: 10.1002/mds.26415. Review.

PMID:
26371623
10.

Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).

Storch A, Schneider CB, Klingelhöfer L, Odin P, Fuchs G, Jost WH, Martinez-Martin P, Koch R, Reichmann H, Chaudhuri KR; NoMoFlu-PD study group, Ebersbach G.

J Neural Transm (Vienna). 2015 Dec;122(12):1673-84. doi: 10.1007/s00702-015-1437-x. Epub 2015 Aug 12.

PMID:
26264174
11.

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.

Trenkwalder C, Chaudhuri KR, García Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Döring F, Henriksen T, Sesar Á, Poewe W; Expert Consensus Group for Use of Apomorphine in Parkinson's Disease, Baker M, Ceballos-Baumann A, Deuschl G, Drapier S, Ebersbach G, Evans A, Fernandez H, Isaacson S, van Laar T, Lees A, Lewis S, Martínez Castrillo JC, Martinez-Martin P, Odin P, O'Sullivan J, Tagaris G, Wenzel K.

Parkinsonism Relat Disord. 2015 Sep;21(9):1023-30. doi: 10.1016/j.parkreldis.2015.06.012. Epub 2015 Jun 17. Review.

PMID:
26189414
12.

Infusion Therapies and Development of Impulse Control Disorders in Advanced Parkinson Disease: Clinical Experience After 3 Years' Follow-up.

Todorova A, Samuel M, Brown RG, Chaudhuri KR.

Clin Neuropharmacol. 2015 Jul-Aug;38(4):132-4. doi: 10.1097/WNF.0000000000000091.

PMID:
26166238
13.

King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.

Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P; EUROPAR and the IPMDS Non Motor PD Study Group.

Mov Disord. 2015 Oct;30(12):1623-31. doi: 10.1002/mds.26270. Epub 2015 Jun 11.

PMID:
26096067
14.

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.

Antonini A, Bauer L, Dohin E, Oertel WH, Rascol O, Reichmann H, Schmid M, Singh P, Tolosa E, Chaudhuri KR.

Eur J Neurol. 2015 Oct;22(10):1400-7. doi: 10.1111/ene.12757. Epub 2015 Jun 22.

PMID:
26095948
15.

Non-motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non-motor subtypes.

Zis P, Martinez-Martin P, Sauerbier A, Rizos A, Sharma JC, Worth PF, Sophia R, Silverdale M, Chaudhuri KR.

Eur J Neurol. 2015 Aug;22(8):1145-50. doi: 10.1111/ene.12733. Epub 2015 May 15.

PMID:
25981492
16.

Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses.

Bhidayasiri R, Chaudhuri KR, LeWitt P, Martin A, Boonpang K, van Laar T.

Clin Neuropharmacol. 2015 May-Jun;38(3):89-103. doi: 10.1097/WNF.0000000000000082.

PMID:
25970277
17.

Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease.

Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, Agüera-Ortiz L, Weintraub D, Riesco A, Kurtis MM, Chaudhuri KR.

Parkinsonism Relat Disord. 2015 Jun;21(6):629-34. doi: 10.1016/j.parkreldis.2015.03.024. Epub 2015 Apr 9.

PMID:
25892660
18.

Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease.

Erro R, Picillo M, Amboni M, Moccia M, Vitale C, Longo K, Pellecchia MT, Santangelo G, Martinez-Martin P, Chaudhuri KR, Barone P.

Mov Disord. 2015 Mar;30(3):373-8. doi: 10.1002/mds.26076. Epub 2015 Feb 4.

PMID:
25648938
19.

The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: a simple grading system.

Chaudhuri KR, Sauerbier A, Rojo JM, Sethi K, Schapira AH, Brown RG, Antonini A, Stocchi F, Odin P, Bhattacharya K, Tsuboi Y, Abe K, Rizos A, Rodriguez-Blazquez C, Martinez-Martin P.

Parkinsonism Relat Disord. 2015 Mar;21(3):287-91. doi: 10.1016/j.parkreldis.2014.12.031. Epub 2015 Jan 5.

PMID:
25616694
20.

Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.

Martínez-Martín P, Rodríguez-Blázquez C, Mario Alvarez, Arakaki T, Arillo VC, Chaná P, Fernández W, Garretto N, Martínez-Castrillo JC, Rodríguez-Violante M, Serrano-Dueñas M, Ballesteros D, Rojo-Abuin JM, Chaudhuri KR, Merello M.

Parkinsonism Relat Disord. 2015 Jan;21(1):50-4. doi: 10.1016/j.parkreldis.2014.10.026. Epub 2014 Nov 5.

PMID:
25466406
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk